{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T04:56:23Z","timestamp":1769576183953,"version":"3.49.0"},"reference-count":17,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"accepted":{"date-parts":[[2016,11,15]]},"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1136\/ejhpharm-2016-001052","type":"journal-article","created":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T22:10:24Z","timestamp":1480630224000},"page":"43-47","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Betamethasone dipropionate compounding for cutaneous T-cell lymphoma management"],"prefix":"10.1136","volume":"25","author":[{"given":"Patr\u00edcia","family":"Trindade","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Instituto Portugu\u00eas de Oncologia de Lisboa Francisco Gentil EPE, Lisbon, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Gelpi","sequence":"additional","affiliation":[{"name":"Department of Nanomedicine and Drug Delivery Systems, iMed.UL (Research Institute for Medicines and Pharmaceutical Sciences) Faculdadec de Farm\u00e1cia da Universidade de Lisboa, Lisbon, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Salgado","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Instituto Portugu\u00eas de Oncologia de Lisboa Francisco Gentil EPE, Lisbon, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana","family":"Marto","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Instituto Portugu\u00eas de Oncologia de Lisboa Francisco Gentil EPE, Lisbon, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Machado","sequence":"additional","affiliation":[{"name":"ADEIM, Faculdade de Farm\u00e1cia da Universidade de Lisboa, Lisbon, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinis","family":"Mateus","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Instituto Portugu\u00eas de Oncologia de Lisboa Francisco Gentil EPE, Lisbon, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Humberto","family":"Gon\u00e7alves","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Instituto Portugu\u00eas de Oncologia de Lisboa Francisco Gentil EPE, Lisbon, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M Fernanda","family":"Sachse","sequence":"additional","affiliation":[{"name":"Dermatology Service, Instituto Portugu\u00eas de Oncologia de Lisboa Francisco Gentil EPE, Lisbon, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ant\u00f3nio Melo","family":"Gouveia","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Instituto Portugu\u00eas de Oncologia de Lisboa Francisco Gentil EPE, Lisbon, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2429-7991","authenticated-orcid":false,"given":"Helena","family":"Ribeiro","sequence":"additional","affiliation":[{"name":"Department of Nanomedicine and Drug Delivery Systems, iMed.UL (Research Institute for Medicines and Pharmaceutical Sciences) Faculdadec de Farm\u00e1cia da Universidade de Lisboa, Lisbon, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2016,12,1]]},"reference":[{"key":"2025090703580015000_25.1.43.1","unstructured":"Habif TP . Clinical dermatology\u2014premalignant and malignant nonmelanoma skin tumors. 5th edn. New York: Elsevier, 2010:801\u201347."},{"key":"2025090703580015000_25.1.43.2","doi-asserted-by":"crossref","unstructured":"Rakel D , Rakel RE . Textbook of family medicine\u2014hematology. 8th edn. New York: Elsevier, 2011:877\u201398.","DOI":"10.1016\/B978-1-4377-1160-8.10039-9"},{"key":"2025090703580015000_25.1.43.3","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.5.624"},{"key":"2025090703580015000_25.1.43.4","doi-asserted-by":"crossref","unstructured":"Abeloff MD , Armitage JO , Niederhuber JE , et al . Abeloff's clinical oncology\u2014cutaneous T-cell lymphoma and cutaneous B-cell lymphoma. In: Abeloff's Clinical Oncology , Habermann TM , Pittelkow MR , eds. 4th edn. New York: Elsevier, 2008:2405\u201324.","DOI":"10.1016\/B978-0-443-06694-8.50117-2"},{"key":"2025090703580015000_25.1.43.5","first-page":"655","article-title":"Skin directed therapy for mycosis fungoides: a review","volume":"7","author":"Berthelot","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"2025090703580015000_25.1.43.6","unstructured":"GUIDELINE ICH. Q2 (R1). Validation of analytical procedures: text and methodology. EU: Adopted by CPMP, November 1994, issued as CPMP\/ICH\/381\/95, 2005: 2\u201315."},{"key":"2025090703580015000_25.1.43.7","first-page":"49","volume-title":"Analytical profiles of drug substances","volume":"6","author":"Florey","year":"1977"},{"key":"2025090703580015000_25.1.43.8","unstructured":"GUIDELINE ICH Q 1 A. Stability testing. EU: Adopted by CPMP, November 2003, issued as CPMP\/QWP\/122\/02 December 2003."},{"key":"2025090703580015000_25.1.43.9","unstructured":"GUIDELINE EMEA. Stability testing: of existing active substances and related finished products. Issued as CPMP\/QWP\/122\/02, 2003:5\u201313."},{"key":"2025090703580015000_25.1.43.10","unstructured":"European Pharmacopeia 7.0. Efficacy of antimicrobial preservation, European Department for the Quality of Medicines within the Council of Europe, Strasbourg, section 5.1.3, 2009:528\u20139."},{"key":"2025090703580015000_25.1.43.11","unstructured":"OECD. Guidance document for the conduct of skin absorption studies. Paris: Organization for Economic Cooperation and Development, 2004."},{"key":"2025090703580015000_25.1.43.12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.0630"},{"key":"2025090703580015000_25.1.43.13","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1159\/000095254","article-title":"Percutaneous absorption of steroids: determination of in vitro permeability and tissue reservoir characteristics in human skin layers","volume":"19","author":"Magnusson","year":"2006","journal-title":"Skin Pharmacol Physi"},{"key":"2025090703580015000_25.1.43.14","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/ejlt.201000495","article-title":"Topical emulsions containing ceramides: effects on the skin barrier function and anti-inflammatory properties","volume":"8","author":"Carneiro","year":"2011","journal-title":"Eur J Lipid Sci Technol"},{"key":"2025090703580015000_25.1.43.15","first-page":"177","article-title":"Stratum corneum reservoir for drugs","volume":"12","author":"Vickers","year":"1972","journal-title":"Adv Biol Skin"},{"key":"2025090703580015000_25.1.43.16","unstructured":"Safety Assessment of Polysorbates as Used in Cosmetics, C.I.R, Report, March 2015."},{"key":"2025090703580015000_25.1.43.17","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.ejca.2006.01.025","article-title":"EORTC consensus recommendations for the treatment of mycosis fungoides\/S\u00e9zary syndrome","volume":"8","author":"Trautinger","year":"2006","journal-title":"Eur J Cancer"}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2016-001052","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T10:58:10Z","timestamp":1757242690000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2016-001052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,1]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12,19]]},"published-print":{"date-parts":[[2018,1]]}},"alternative-id":["10.1136\/ejhpharm-2016-001052"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2016-001052","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"value":"2047-9956","type":"print"},{"value":"2047-9964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,1]]}}}